Skip to content

Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland

Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04546191
Enrollment
1580
Registered
2020-09-11
Start date
2020-07-01
Completion date
2020-09-01
Last updated
2020-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Keywords

Covid19, Symptoms, Well being, Survey

Brief summary

The purpose of this cross-sectional study is to explore symptoms and well being of people diagnosed with COVID-19 from the outset of the pandemic until June 2020.

Detailed description

All patients diagnosed with COVID-19 in Iceland were referred to the COVID-19 outpatient clinic at Landspitali National University Hospital in Iceland. In the clinic risk assessment was conducted and the patients were accordingly provided with individualized care be it telephone surveillance, onsite examination and treatment, or admission to the hospital. As the the first wave of the pandemic was curbing the necessity of exploring how the patients did and continue to fare after being infected became apparent. The research questions are: What were the symptoms that patients expressed during and about three months after being diagnosed with COVID-19? What is the prevalence and intensity of the symptoms that patients expressed during and about three months after being diagnosed with COVID-19 ? How do patients value their health related quality of life, what is their health literacy and sense of security in care during and about three months after being diagnosed with COVID-19 ? How do patients value the nursing care in the outpatient COVID-19 clinic? What are the patients' perception of having caught COVID-19?

Interventions

None listed

Sponsors

Landspitali University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients receiving care from the COVID-19 outpatient clinic at LUH during the first wave of the pandemic

Exclusion criteria

* Young than 18 y.o. * Do not understand Icelandic * Died

Design outcomes

Primary

MeasureTime frameDescription
Symptoms2 monthsPatients answer a questionnaire developed by authors based on published symptoms of COPVID19. The questionnare has two versions one refers to symptoms during the quarantine and the other to the time a couple of months later. Name: Symptoms during and after the COVID 19 quarantine. The questionnaire has 25 items scored on a four point Likert scale. The highest possible score is 100 and the lowest possible score is 20. Higher score means worse outcome.

Secondary

MeasureTime frameDescription
Wellbeing - HRQL2 monthsEQ-5D is a generic health related quality of life measurement (HRQL). It is composed of five dimensions; mobility, self-care, usual activities, pain/discomfort and anxiety/depression measured on five levels (from no problems to extreme problems or unable) with a minimum score 5 and maximum score 25, with higher score indicating worse outcome. The instrument contains as well a visual analogue scale (VAS) measuring the person's health state today, on a 100 point scale (worst imaginable to best imaginable health state).

Other

MeasureTime frameDescription
Anxiety and depression (HADS)2 monthsHospital Anxiety and Depression Scale (HADS) is a widely used instrument to assess anxiety and depression in people attending outpatient hospital clinics. Sensitive to mild disturbances, HADS is a reliable and valid instrument consisting of a 14 item 4 point (0-3) Likert scale with two subscales; anxiety (7 items) and depression (7 items). The minimum score is 0 and the highest possible score is 42. Higher score refers to worse outcome.

Countries

Iceland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026